Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

(2014) D. K. Sato et al.   NEUROLOGY

Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders

(2013) D. K. Sato et al.   NEUROLOGY

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype

(2012) J. Kitley et al.   NEUROLOGY

Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders

(2011) Simone Mader et al.   Journal of Neuroinflammation

Astrocytic damage is far more severe than demyelination in NMO: A clinical CSF biomarker study

(2010) R. Takano et al.   NEUROLOGY

Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo

(2009) Monika Bradl et al.   ANNALS OF NEUROLOGY